HUM Valuation Metrics
HUM Stock Price Metrics
HUM Dividend Metrics
HUM Growth Rate Metrics
HUM Discounted Cash Flow Metrics
| Fair Value Price | $729.53 |
| Margin of Safety | 99.92% |
HUM Revenue Metrics
HUM PE Ratio Metrics
| PE Ratio | 39.03 |
| PE Ratio Avg TTM | 21.88 |
| PE Ratio Avg 3Y | 21.26 |
| Current VS TTM Avg | +78.35% |
| Current VS 3Y Avg | +83.62% |
| Current VS 5Y Avg | +85.18% |
HUM PS Ratio Metrics
| PS Ratio | 0.32 |
| PS Ratio Avg TTM | 0.24 |
| PS Ratio Avg 3Y | 0.36 |
| Current VS TTM Avg | +35.64% |
| Current VS 3Y Avg | -10.02% |
| Current VS 5Y Avg | -34.47% |
HUM PB Ratio Metrics
| PB Ratio | 2.37 |
| PB Ratio Avg TTM | 1.64 |
| PB Ratio Avg 3Y | 2.30 |
| Current VS TTM Avg | +44.79% |
| Current VS 3Y Avg | +3.00% |
| Current VS 5Y Avg | -18.56% |
HUM Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 34.61 |
| PFCF Ratio Avg TTM | 25.46 |
| PFCF Ratio Avg 3Y | 17.19 |
| Current VS TTM Avg | +35.93% |
| Current VS 3Y Avg | +101.36% |
| Current VS 5Y Avg | +26.17% |
HUM Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.73 |
| Debt/Equity Ratio Avg TTM | 0.74 |
| Debt/Equity Ratio Avg 3Y | 0.75 |
| Current VS TTM Avg | -1.35% |
| Current VS 3Y Avg | -2.67% |
| Current VS 5Y Avg | +0.92% |
HUM PEG Ratio Metrics
| PEG Ratio | - |
| PEG Ratio Avg TTM | - |
| PEG Ratio Avg 3Y | - |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | - |
HUM FCF Yield
| FCF Yield | 2.89% |
| FCF Yield Avg TTM | 5.40% |
| FCF Yield Avg 3Y | 8.83% |
| Current VS TTM Avg | -46.48% |
| Current VS 3Y Avg | -67.28% |
| Current VS 5Y Avg | -59.67% |
HUM Earnings Yield
| Earnings Yield | 2.56% |
| Earnings Yield Avg TTM | 4.76% |
| Earnings Yield Avg 3Y | 4.86% |
| Current VS TTM Avg | -46.21% |
| Current VS 3Y Avg | -47.34% |
| Current VS 5Y Avg | -47.33% |
HUM EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 38.35 |
| Ev/Ebit Ratio Avg TTM | 22.15 |
| Ev/Ebit Ratio Avg 3Y | 19.20 |
| Current VS TTM Avg | +73.17% |
| Current VS 3Y Avg | +99.78% |
| Current VS 5Y Avg | +103.96% |
HUM EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 18.61 |
| Ev/Ebitda Ratio Avg TTM | 11.68 |
| Ev/Ebitda Ratio Avg 3Y | 11.33 |
| Current VS TTM Avg | +59.31% |
| Current VS 3Y Avg | +64.23% |
| Current VS 5Y Avg | +50.54% |
HUM EV/Assets Ratio Metrics
| Ev/Assets Ratio | 0.96 |
| Ev/Assets Ratio Avg TTM | 0.75 |
| Ev/Assets Ratio Avg 3Y | 0.88 |
| Current VS TTM Avg | +27.37% |
| Current VS 3Y Avg | +9.70% |
| Current VS 5Y Avg | -12.76% |
HUM EV/Sales Ratio Metrics
| Ev/Sales Ratio | 0.39 |
| Ev/Sales Ratio Avg TTM | 0.30 |
| Ev/Sales Ratio Avg 3Y | 0.40 |
| Current VS TTM Avg | +29.25% |
| Current VS 3Y Avg | -2.66% |
| Current VS 5Y Avg | -27.59% |
HUM Current Ratio Metrics
| Current Ratio | 0.72 |
| Current Ratio Avg TTM | 0.58 |
| Current Ratio Avg 3Y | 0.57 |
| Current VS TTM Avg | +24.14% |
| Current VS 3Y Avg | +25.22% |
| Current VS 5Y Avg | +25.22% |
HUM Quick Ratio Metrics
| Quick Ratio | 0.72 |
| Quick Ratio Avg TTM | 0.58 |
| Quick Ratio Avg 3Y | 0.57 |
| Current VS TTM Avg | +24.14% |
| Current VS 3Y Avg | +25.22% |
| Current VS 5Y Avg | +25.22% |
HUM ROIC Metrics
| ROIC | 3.12% |
| ROIC Avg 3Y | 5.37% |
| ROIC Avg 5Y | 7.01% |
| Current VS 3Y Avg | -41.85% |
| Current VS 5Y Avg | -55.51% |
| Current VS 10Y Avg | -57.39% |
HUM Return on Assets Metrics
| ROA | 2.44 |
| ROA Avg TTM | 2.52 |
| ROA Avg 3Y | 4.20 |
| Current VS TTM Avg | -3.37% |
| Current VS 3Y Avg | -41.84% |
| Current VS 5Y Avg | -55.54% |
HUM Return on Equity Metrics
| ROE | 6.73 |
| ROE Avg TTM | 7.05 |
| ROE Avg 3Y | 11.93 |
| Current VS TTM Avg | -4.54% |
| Current VS 3Y Avg | -43.61% |
| Current VS 5Y Avg | -55.39% |
HUM Net Profit Margin Metrics
| Net Profit Margin | 0.92% |
| Net Profit Margin Avg TTM | 0.97% |
| Net Profit Margin Avg 3Y | 1.82% |
| Current VS TTM Avg | -5.15% |
| Current VS 3Y Avg | -49.59% |
| Current VS 5Y Avg | -63.61% |
Last Updated: Wednesday, June 10, 2026
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin